Professor George Dickson

  1. In vivo evaluation of muscle specific synthetic promoters

    Dickson, G.

    SynPromics Ltd: £67,992

    1/08/1730/04/18

    Project: Research

  2. Genome Editing in Muscle Stem Cells for Duchenne Muscular Dystrophy

    Dickson, G.

    Rosetrees Trust: £20,000

    1/02/1731/01/18

    Project: Other

  3. In vivo activity assessment of four AAV OPMD clinical constructs – Phase1

    Dickson, G.

    Benitec Ltd: £13,998

    1/09/1631/07/17

    Project: Research

  4. Inducing Immune-Tolerance to AAV Vector Capsid for Gene Therapy of Duchenne Muscular Dystrophy

    Dickson, G.

    Jesse's Journey: £102,041, Jesse's Journey: £59,172

    1/10/1530/09/18

    Project: Research

  5. Second generation hyper-active micro-dystrophin AAV vectors for Duchenne muscular dystrophy gene therapy

    Dickson, G.

    Muscular Dystrophy Campaign: £59,965, Muscular Dystrophy Campaign: £57,679, Muscular Dystrophy Campaign: £56,456

    1/10/1530/09/18

    Project: Research

  6. Stage 2 study on DNA-directed RNAi for the treatment of OPMd

    Dickson, G.

    Benitec Ltd: £19,981, Benitec Ltd: £408,200

    1/09/1531/08/16

    Project: Research

  7. Towards a clinical trial for Oculopharyngeal Muscular Dystrophy (OPMD)

    Dickson, G.

    Association Francais contre les Myopathies: £202,546

    1/07/141/07/17

    Project: Research

  8. Correction of Duchenne Muscular Dystrophy Mutations using Endonuclease-Mediated Genome Surgery

    Dickson, G.

    Muscular Dystrophy Campaign: £26,568, Muscular Dystrophy Campaign: £26,568

    1/10/1330/09/14

    Project: Research

  9. Development of dual/triple transpliced AAV vectors to restore quasi/full length dystrophin variants to muscle

    Dickson, G.

    Muscular Dystrophy Campaign: £58,425, Muscular Dystrophy Campaign: £60,087, Muscular Dystrophy Campaign: £60,087, Muscular Dystrophy Campaign: £61,794

    1/10/1330/09/16

    Project: Research

  10. Gene Surgery for Duchenne Muscular Dystrophy(DMD)

    Dickson, G. & Yáñez-Muñoz, R. J.

    Association Francais contre les Myopathies: £224,060

    1/04/1331/03/15

    Project: Research

  11. Combination Antisense Treatment for Duchenne Muscular Dystrophy: Open Reading Frame Rescue of Dystrophin in conjunction with Destructive Exon Skipping of Myostatin mRNA

    Dickson, G.

    Muscular Dystrophy Campaign: £40,675, Muscular Dystrophy Campaign: £41,556, Muscular Dystrophy Campaign: £42,465

    1/02/1230/03/14

    Project: Research

  12. Pathophysiology and therapeutic approaches in Oculoparyngeal Muscular Dystropy (OPMD)

    Dickson, G.

    Association Francais contre les Myopathies: £120,523

    1/05/1130/04/13

    Project: Research

  13. Advances in oligonucleotide-mediated exon skipping for DMD and related disorders

    Dickson, G.

    Association Francais contre les Myopathies: £105,626

    1/04/1131/03/15

    Project: Research

  14. UK HVC

    Dickson, G.

    Wellcome Trust: £132,000, Wellcome Trust: £20,000, Wellcome Trust: £50,000

    1/02/1131/01/13

    Project: Research

  15. Meganuclease-Enhance Genome Correction Therapy for Duchenne Muscular Dystrophy

    Dickson, G.

    Association Francais contre les Myopathies: £35,514, Association Francais contre les Myopathies: £30,508, Association Francais contre les Myopathies: £36,741, Association Francais contre les Myopathies: £15,260, Association Francais contre les Myopathies: £11,647

    1/04/1031/03/12

    Project: Research

  16. Enhancing the therapeutic functionality of AAV vectors encoding dystrophin for preclinical DMD gene therapy studies

    Dickson, G.

    Muscular Dystrophy Campaign: £63,925, Muscular Dystrophy Campaign: £67,006, Muscular Dystrophy Campaign: £67,006

    1/10/0930/09/10

    Project: Research

  17. OPMD: Translational studies towards physiological and genetic therapy for Oculopharyngeal Muscular Dystrophy (OPMD)

    Dickson, G.

    Association Francais contre les Myopathies: £35,505

    1/10/0930/09/10

    Project: Research

  18. Infinite-Epitope Virus-like-Particle Vaccines for HIV/AIDS

    Dickson, G.

    Bill and Melinda Gates Foundation: £66,729

    1/05/0930/04/10

    Project: Research

  19. Second Generation Micro-Dystrophin Gene Therapy for Duchenne Muscular Dystrophy

    Dickson, G.

    Duchenne Ireland: £58,721

    1/04/0930/09/10

    Project: Research

  20. ICE: Towards clinical trials for DMD using gene and cell therapies combined with exon skipping strategies

    Dickson, G.

    Association Monégasque Contre les Myopathies: £58,121

    1/11/0831/10/09

    Project: Research

  21. Trojan Horse Vaccines for HIV Based Lentiviral Vectors Expressing Suicide Enveloppes

    Dickson, G.

    Bill and Melinda Gates Foundation: £54,576

    1/10/0830/09/09

    Project: Research

  22. Development of AAV Vectors Encoding Micro-Dystrophin & GDF8 (Myostatin) Propeptide cDNAs for Preclinical DMD Gene Therapy Studies

    Dickson, G.

    Muscular Dystrophy Campaign: £98,016, Muscular Dystrophy Campaign: £103,720

    1/10/0630/09/07

    Project: Research

  23. Optimization and Efficacy of Transcutaneous “Stealth” Adenovirus Vector Vaccine

    Dickson, G.

    Bill and Melinda Gates Foundation: £160,347, Bill and Melinda Gates Foundation: £134,957, Bill and Melinda Gates Foundation: £80,828, Bill and Melinda Gates Foundation: £16,130, Bill and Melinda Gates Foundation: £83,875, Bill and Melinda Gates Foundation: £105,875

    1/09/0631/08/07

    Project: Research

  24. (CLINIGENE): European Network for the advancement of clinical Gene transfer and therapy (CLINIGENE)

    Dickson, G. & Yáñez-Muñoz, R. J.

    European Union: £60,464, European Union: £13,474, European Commission: £15,044, European Union: £165,991, European Union: £3,874, European Union: £8,716, European Commission: £7,749

    1/06/0630/11/07

    Project: Research

  25. The role of Plasminogen Activator Inhibitor in Muscular Dystrophy

    Dickson, G.

    Wyeth: £50,001

    1/12/0530/11/06

    Project: Research